Cover Image
市場調查報告書

體外受精設備及消耗品的全球市場:市場機會與預測 (2014∼2020年)

In vitro Fertilization Devices and Consumables Market - Opportunities and Forecasts, 2014 - 2020

出版商 Allied Market Research 商品編碼 354612
出版日期 內容資訊 英文 149 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
體外受精設備及消耗品的全球市場:市場機會與預測 (2014∼2020年) In vitro Fertilization Devices and Consumables Market - Opportunities and Forecasts, 2014 - 2020
出版日期: 2016年02月01日 內容資訊: 英文 149 Pages
簡介

全球體外受精設備及消耗品市場預測到2020年前將以年複合成長率19.7%擴大,並達到30億2,520萬美元。不孕症的罹患率上升和體外受精的增加,醫療費擴大等大大推動了市場的成長。近年來的技術創新預測也將擴大市場的需求。

本報告提供全球體外受精設備及消耗品市場現狀與到2020年前的成長預測,提供您不同設備,試劑·培養基,各技術,各終端用戶,及各地區趨勢,加上市場趨勢與課題,並彙整主要企業的簡介等資訊。

第1章 簡介

第2章 摘要整理

第3章 市場概要

  • 市場定義和範圍
  • 替代技術
  • 從藥物和手術轉換到體外受精
  • 體外受精有關的成本
  • 體外受精市場上捐贈者所扮演的角色
  • 代理母親
  • 同性婚伴侶的體外受精趨勢
  • 體外受精的最新技術
  • 不孕治療與性別選擇
  • 胚篩檢方法的代謝體學
  • 體外受精的幹細胞的應用
  • 缺乏體外受精和資源的國家
  • 主要調查結果
  • 波特五力分析
  • 價值鏈分析
  • 專利分析
  • 法律規章上的課題和法規
  • 保險償付方案
  • 臨床實驗
  • 促進要素
  • 阻礙要素
  • 機會

第4章 全球體外受精設備及消耗品市場:不同設備

  • 不同設備市場
  • 配件及拋棄式

第5章 全球體外受精設備及消耗品市場:試劑·培養基別

  • 試劑·培養基別市場
  • 精子加工培養基
  • 胚珠加工培養基
  • 胚培養基

第6章 全球體外受精設備及消耗品市場:各技術

  • 各技術市場
  • 新鮮胚移植技術
  • 凍結胚移植技術
  • 捐贈者胚珠體外受精技術

第7章 全球體外受精設備及消耗品市場:各終端用戶

  • 各終端用戶市場
  • 醫院
  • 外科中心
  • 臨床研究機關
  • 診療所

第8章 全球體外受精設備及消耗品市場:各地區

  • 北美
  • 歐洲
  • 亞太地區
  • 南美·中東·非洲

第9章 企業簡介

  • Vitrolife AB
  • EMD Serono, Inc.
  • Irvine Scientific
  • CooperSurgical, Inc. (Origio)
  • Cook Medical, Inc.
  • Thermo Fisher Scientific Inc.
  • Genea Biomedx
  • Auxogyn, Inc.
  • Oxford Gene Technology
  • Ovascience Inc.

圖表

目錄

Title: In vitro Fertilization Devices and Consumables Market by Device (Sperm Separation System, Cryosystem, Incubators, Imaging System, Ovum Aspiration Pump, Cabinet, Micromanipulator system, Accessories and Disposables), Reagents & Media (Cryopreservation Media, Semen Processing Media, Ovum Processing Media, Embryo Culture Media), Technique (Fresh Embryo IVF, Frozen Egg IVF, Donor Egg IVF) and End User (Clinics, Hospitals, Surgical Centres, Clinical Research Institutes) - Opportunities and Forecasts, 2014 - 2020.

In vitro fertilization (IVF) is a type of assisted reproductive technology in which the ovum is artificially fertilized in laboratory settings and then implanted into the uterus. IVF is a widely popular treatment, adopted by couples with infertility problems, single mothers, and the LGBT community to procreate.

The world in vitro fertilization devices and consumables market is projected to garner $3,025.2 mllion by 2020, registering a CAGR of 19.7% over the forecast period. The world IVF devices & consumables market is growing significantly owing to rising incidences of infertility, developments in IVF procedures, and growing healthcare expenditures. Furthermore, the rising awareness about infertility and easy availability of IVF treatments, would drive the market growth. Recent technological innovations in the IVF technology, such as embryoscope and capsule IVF, are expected to drive the demand for IVF devices and consumables in future. However, strenuous maintenance issues and inherent high cost associated with the devices limit the growth of the market. The shift in adoption of conventional infertility treatments such as infertility-medication (clomid), to the advanced IVF technologies would boost numerous growth opportunities for the IVF devices market. However, unaffordability of high-end IVF devices is the major challenge faced by local IVF clinics.

The world IVF devices market is segmented into IVF devices, reagent & media, techniques, end users, and geography. The devices considered in this report include sperm separation system, cryosystem, incubator, imaging system, ovum aspiration pump, IVF cabinet, micromanipulator, and IVF-accessories & disposables among others. The capital equipment set up is the fastest growing segment owing to the increasing number of newly established IVF centers. However, disposables and consumables used during IVF procedures are the highest revenue generating segments.

Based on reagents & media, the market is categorized into, cryopreservation media, semen processing media, ovum processing media and embryo culture media. Cryopreservation media is the highest revenue generating segment owing to its large application during frozen IVF cycles. IVF devices and consumables market by techniques is categorized into, fresh embryo IVF, frozen egg IVF and donor egg IVF. Fresh embryo IVF cycles is the largest revenue generating segment, owing to growing number of couples opting for fresh IVF cycles. The world IVF devices market by end-users is segmented into clinics, hospitals, surgical centres and clinical research institutes. Fertility clinic is the highest revenue generating segment, owing to short patient wait time and higher success rate.

The world IVF devices market is analysed on the basis of geographical regions into North America, Europe, Asia-Pacific, and LAMEA. North America and Europe are the leading revenue generating regions, collectively accounted for about 80% of the market share in 2015. However, the Asia-Pacific region would be the fastest growing region, owing to the high demand for economic IVF services and availability of skilled workforce.Product launch is one of the key strategies adopted by prominent players in the IVF devices and consumables market for the launch of micromanipulators systems, ovum aspiration pumps and IVF accessories among others. These technologies are used in both clinical and research fields. Companies profiled in this report include Vitrolife AB, EMD Serono, Inc., Irvine Scientific, CooperSurgical, Inc., Cook Medical, Inc., Thermo Fisher Scientific, Inc., Genea Biomedx, Auxogyn, Inc., Oxford Gene Technology, and OvaScience Inc.

KEY MARKET BENEFITS

  • An in-depth analysis of current research and clinical developments within world IVF devices market is provided with key market dynamic factors that help in understanding the behavior of market.
  • The report provides quantitative analysis of the current market and estimations through 2014-2020, which assists in identifying the prevailing market opportunities.
  • A comprehensive analysis of the market scenario in terms of devices, accessories & disposables and reagents & media helps in identifying the prevailing opportunities in the world IVF devices & consumables market.
  • An in-depth analysis of current research and developments in the world IVF devices and consumables market provides key market dynamic factors shapes the market dynamics.
  • Geographically, the world IVF devices and consumables market is analyzed based on various regions such as North America, Europe, Asia-Pacific, and LAMEA.
  • Competitive intelligence (of leading manufacturers and distributors of IVF devices) highlights the business practices followed by leading market players across the geographies.
  • SWOT analysis enables to study the internal environment of prominent companies for strategy formulation.
  • Extensive analysis of the market is conducted by closely following key product positioning and monitoring the top contenders.

IN VITRO FERTILIZATION DEVICES AND CONSUMABLES MARKET KEY SEGMENTS:

The world IVF devices market is segmented on the basis of instruments, reagents & media, techniques, end users, and geography.

By Device

  • Sperm Separation System
  • Cryosystem
  • Incubators
  • Imaging System
  • Ovum Aspiration Pump
  • Cabinet
  • Micromanipulator system
  • Accessories and Disposables
  • Others

By Reagents & Media

  • Cryopreservation Media
  • Semen Processing Media
  • Ovum Processing Media
  • Embryo Culture Media

By Technique

  • Fresh Embryo IVF
  • Frozen Egg IVF
  • Donor Egg IVF

By End User

  • Clinics
  • Hospitals
  • Surgical Centres
  • Clinical Research Institutes

By Geography

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • Germany
    • United Kingdom
    • Other Europe
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • Others
  • LAMEA
    • Latin America
    • The Middle East
    • Africa

Table of Contents

CHAPTER 1: INTRODUCTION

  • 1.1. Report description
  • 1.2. Key market benefits
  • 1.3. Key market segments
  • 1.4. Key audiences
  • 1.5. Research methodology
    • 1.1.1. Secondary research
    • 1.1.2. Primary research
    • 1.1.3. Analyst tools and models

CHAPTER 2: EXECUTIVE SUMMARY

CHAPTER 3: GLOBAL IVF DEVICES & CONSUMABLES MARKET OVERVIEW

  • 3.1. Market definition and scope
  • 3.2. Alternative technologies
    • 3.2.1. Intrauterine Insemination (IUI) Technique
      • 3.2.1.1. Factors assessed for the procedure
      • 3.2.1.2. Benefits of this technique
      • 3.2.1.3. Risks
    • 3.2.2. Difference between IUI and IVF technique
    • 3.2.3. GIFT technique
      • 3.2.3.1. Difference between GIFT and IVF technique
    • 3.2.4. ZIFT technique
      • 3.2.4.1. Differences between ZIFT and IVF technique
  • 3.3. Replacing IVF procedures by fertility drugs and surgeries
    • 3.3.1. Female infertility treatments
      • 3.3.1.1. Limitations of fertility drugs
    • 3.3.2. Male infertility treatments
  • 3.4. Costs related to IVF procedures
  • 3.5. Role of donors in the IVF market
    • 3.5.1. Egg donation
    • 3.5.2. Egg sharing
    • 3.5.3. Sperm donation
    • 3.5.4. Embryo donation/adoption
    • 3.5.5. Donation for research
  • 3.6. Surrogacy
    • 3.6.1. Legal issues
  • 3.7. IVF trends in same sex couples
    • 3.7.1. Artificial insemination
    • 3.7.2. Surrogate mothers
    • 3.7.3. In-vitro fertilization
  • 3.8. Advanced IVF technologies
    • 3.8.1. Capsule IVF
    • 3.8.2. Three parent IVF
      • 3.8.2.1. Ethical concerns
    • 3.8.3. Mini IVF
      • 3.8.3.1. Advantages
      • 3.8.3.2. Drawbacks
    • 3.8.4. EmbryoScope
      • 3.8.4.1. Advantages
    • 3.8.5. PICSI
  • 3.9. Fertility treatment and gender selection
    • 3.9.1. Methods of sex selection
      • 3.9.1.1. Gradient method
      • 3.9.1.2. Flow cytometry technique
      • 3.9.1.3. Pre-implantation genetic diagnosis (PGD)
      • 3.9.1.4. Ethical and legal issues
  • 3.10. Metabolomics in embryo screening methods
  • 3.11. Application of stem cells in IVF
  • 3.12. IVF and resource poor countries
  • 3.13. Key Findings
    • 3.13.1. Top factors impacting
    • 3.13.2. Top investment pockets
    • 3.13.3. Top winning strategies
  • 3.14. Porters five forces analysis
    • 3.14.1. High competition and large number reduces the power of suppliers
    • 3.14.2. Scattered nature and large count of end users moderates the buyer power
    • 3.14.3. High capital cost lowers the threat of new entrants
    • 3.14.4. Industry rivalry is intense due to presence of few dominant competitors
    • 3.14.5. Lack of efficient substitutes lowers the threat from substitutes
  • 3.15. Value chain analysis
  • 3.16. Patent analysis
    • 3.16.1. Patent analysis by type of patents
    • 3.16.2. Patents Analysis by geography
  • 3.17. Regulatory issues and legislations
  • 3.18. Insurance reimbursement scenario
  • 3.19. Clinical trials
    • 3.19.1. Trial 1: To study the DHEA outcomes on poor responders of IVF
    • 3.19.2. Trial 2: Use of Metformin in IVF treatment of polycystic ovary syndrome
    • 3.19.3. Trial 3- Treatment of first line unexplained infertility by IVF and IUI in controlled ovarian stimulation
    • 3.19.4. Trial 4: Fast track to IVF (FASTT) Vs conventional infertility treatment
    • 3.19.5. Trial 5: To study the evaluation of multiple doses of NT100 in women with repeated IVF failures
  • 3.20. Drivers
    • 3.20.1. Delayed pregnancies in women
    • 3.20.2. Rise in global infertility rates
    • 3.20.3. Advancement in technology
    • 3.20.4. Rise in gamete donations
    • 3.20.5. Rise in disposable income
    • 3.20.6. Increase in success rates
  • 3.21. Restraints
    • 3.21.1. Cost constraints
    • 3.21.2. Ethical and legal issues
    • 3.21.3. Multiple pregnancies
    • 3.21.4. Low awareness level
  • 3.22. Opportunities
    • 3.22.1. Fertility tourism
    • 3.22.2. Growing number of fertility clinics
    • 3.22.3. Rise in same sex marriages

CHAPTER 4: GLOBAL IVF DEVICES & CONSUMABLES MARKET BY INSTRUMENTS

  • 4.1. Global IVF market by instrument, 2014-2020, ($million)
    • 4.1.1. Incubators
      • 4.1.1.1. Global IVF incubators market by geography
    • 4.1.2. Cryosystem
      • 4.1.2.1. Global IVF cryosystem market by geography
    • 4.1.3. Imaging system
      • 4.1.3.1. Global IVF Imaging system market by geography
    • 4.1.4. Cabinet (work station)
      • 4.1.4.1. Global IVF cabinets market by geography
    • 4.1.5. Ovum aspiration pump
      • 4.1.5.1. Global IVF ovum aspiration pump market by geography
    • 4.1.6. Sperm separation system
      • 4.1.6.1. Global IVF Sperm separation system market by geography
    • 4.1.7. Micro manipulator system
      • 4.1.7.1. Global IVF Micromanipulator market by geography
    • 4.1.8. Others
      • 4.1.8.1. Global IVF other instruments market by geography
  • 4.2. Accessories and disposables
    • 4.2.1. Semen analysis chamber
    • 4.2.2. Plastic ware
    • 4.2.3. Oocyte retrieval needles
    • 4.2.4. Miscellaneous disposables
    • 4.2.5. Global IVF accessories and disposables market by geography

CHAPTER 5: GLOBAL IVF DEVICES & CONSUMABLES MARKET, BY REAGENTS & MEDIA

  • 5.1. Global IVF market by reagents & media, 2014-2020, ($million)
  • 5.2. Cryopreservation media
    • 5.2.1. Embryo cryopreservation media
    • 5.2.2. Sperm cryopreservation media
    • 5.2.3. Oocyte cryopreservation media
    • 5.2.4. Global IVF cryopreservation media market by geography
  • 5.3. Semen processing media
    • 5.3.1. Global IVF semen processing media market by geography
  • 5.4. Ovum processing media
    • 5.4.1. Global IVF ovum processing media market by geography
  • 5.5. Embryo culture media
    • 5.5.1. Global IVF embryo culture media market by geography

CHAPTER 6: GLOBAL IVF DEVICES & CONSUMABLES MARKET, BY TECHNIQUE

  • 6.1. Global IVF market, by technique, 2014-2020 ($Million)
  • 6.2. Fresh embryo transfer technique
    • 6.2.1. Drivers
      • 6.2.1.1. trends of Delayed pregnancies
      • 6.2.1.2. Growing rates of infertility
    • 6.2.2. Restraints
      • 6.2.2.1. Cost involved in the treatment
      • 6.2.2.2. reimbursements issues with fresh embryo ivf cycles
    • 6.2.3. Global fresh embryo IVF cycle market, by geography
  • 6.3. Frozen Embryo Transfer technique (FER)
    • 6.3.1. Reasons to use this technique
    • 6.3.2. Advantages of Frozen egg IVF technique
    • 6.3.3. Disadvantages of frozen egg IVF technique
    • 6.3.4. Global frozen egg IVF cycle market, by geography
  • 6.4. Donor Egg IVF technique
    • 6.4.1. Benefits of donor egg IVF technique
    • 6.4.2. Risks associated with donor egg IVF cycle technique
    • 6.4.3. Global donor egg IVF cycle market by geography

CHAPTER 7: GLOBAL IVF DEVICES & CONSUMABLES MARKET, BY END USERS

  • 7.1. Global IVF market by end user, 2014-2020 ($Million)
  • 7.2. Hospitals
    • 7.2.1. Global IVF hospitals market by geography
  • 7.3. Surgical centers
  • 7.4. Clinical research institutes
    • 7.4.1. Global IVF clinical research institutes market by geography
  • 7.5. Clinics
    • 7.5.1. Global IVF Clinics market by geography

CHAPTER 8: GLOBAL IVF DEVICES & CONSUMABLES MARKET, BY GEOGRAPHY

  • 8.1. North America
    • 8.1.1. North America IVF devices and consumables market, by country
      • 8.1.1.1. United States IVF devices and consumables market
      • 8.1.1.2. Canada IVF devices and consumables market
      • 8.1.1.3. Mexico IVF devices and consumables market
  • 8.2. Europe
    • 8.2.1. Europe IVF devices and consumables market, by component
      • 8.2.1.1. Germany IVF devices and consumables market
      • 8.2.1.2. France IVF devices and consumables market
      • 8.2.1.3. United Kingdom IVF devices and consumables market
      • 8.2.1.4. Other Europe IVF devices and consumables market
  • 8.3. Asia-Pacific
    • 8.3.1. Asia-Pacific IVF devices & consumables market, by component
      • 8.3.1.1. India IVF devices & consumables market
      • 8.3.1.2. China IVF devices & consumables market
      • 8.3.1.3. Japan IVF devices & consumables market
      • 8.3.1.4. Australia IVF devices & consumables market
      • 8.3.1.5. other Asia-pacific IVF devices & consumables market
  • 8.4. LAMEA
    • 8.4.1. LAMEA IVF devices & consumables market, by component
      • 8.4.1.1. Latin America IVF devices & consumables market
      • 8.4.1.2. Middle East IVF devices & consumables market
      • 8.4.1.3. Africa IVF devices & consumables market

CHAPTER 9: COMPANY PROFILE

  • 9.1. Vitrolife AB
    • 9.1.1. Company overview
    • 9.1.2. Business performance
    • 9.1.3. Strategic moves and developments
    • 9.1.4. SWOT analysis of Vitrolife AB
  • 9.2. EMD Serono, Inc.
    • 9.2.1. Company overview
    • 9.2.2. Business performance
    • 9.2.3. Strategic moves and developments
    • 9.2.4. SWOT analysis of EMD Serono, Inc.
  • 9.3. Irvine Scientific
    • 9.3.1. Company overview
    • 9.3.2. Business performance
    • 9.3.3. Strategic moves and developments
    • 9.3.4. SWOT analysis of Irvine scientific
  • 9.4. CooperSurgical, Inc. (Origio)
    • 9.4.1. Company overview
    • 9.4.2. Business performance
    • 9.4.3. Strategic moves and developments
    • 9.4.4. SWOT analysis of CooperSurgical, Inc.
  • 9.5. Cook Medical, Inc.
    • 9.5.1. Company overview
    • 9.5.2. Strategic moves and developments
    • 9.5.3. SWOT analysis of Cook medical, Inc.
  • 9.6. Thermo Fisher Scientific Inc.
    • 9.6.1. Company overview:
    • 9.6.2. Business performance
    • 9.6.3. Strategic moves and developments
    • 9.6.4. SWOT analysis of Thermo Fisher Scientific, Inc.
  • 9.7. Genea Biomedx
    • 9.7.1. Company overview
    • 9.7.2. Strategic moves and developments
    • 9.7.3. SWOT Analysis of Genea Biomedx
  • 9.8. Auxogyn, Inc.
    • 9.8.1. Company overview
    • 9.8.2. Strategic moves and developments
      • 9.8.2.1. Primary strategies
      • 9.8.2.2. Other strategies
    • 9.8.3. SWOT Analysis of Auxogyn, Inc.
  • 9.9. Oxford Gene Technology
    • 9.9.1. Company overview
    • 9.9.2. Strategic moves and developments
    • 9.9.3. SWOT analysis of Oxford Gene Technology
  • 9.10. Ovascience Inc.
    • 9.10.1. Company overview
    • 9.10.2. Business performance
    • 9.10.3. Strategic moves and developments
    • 9.10.4. SWOT analysis of OvaScience, Inc.

List of Tables

  • TABLE 1: WORLD HOME DCOR MARKET REVENUE BY PRODUCT, 2014-2020 ($MILLION)
  • TABLE 2: WORLD HOME DCOR MARKET REVENUE BY GEOGRAPHY, 2014-2020 ($MILLION)
  • TABLE 3: WORLD FURNITURE MARKET REVENUE BY TYPE, 2014-2020 ($MILLION)
  • TABLE 4: WORLD FURNITURE MARKET REVENUE BY GEOGRAPHY, 2014-2020 ($MILLION)
  • TABLE 5: WORLD KITCHEN FURNITURE MARKET REVENUE BY GEOGRAPHY, 2014-2020 ($MILLION)
  • TABLE 6: WORLD LIVING & BEDROOM FURNITURE MARKET REVENUE BY GEOGRAPHY, 2014-2020 ($MILLION)
  • TABLE 7: WORLD BATHROOM FURNITURE MARKET REVENUE BY GEOGRAPHY, 2014-2020 ($MILLION)
  • TABLE 8: WORLD OUTDOOR FURNITURE MARKET REVENUE BY GEOGRAPHY, 2014-2020 ($MILLION)
  • TABLE 9: WORLD LIGHTING FURNITURE MARKET REVENUE BY GEOGRAPHY, 2014-2020 ($MILLION)
  • TABLE 10: WORLD HOME TEXTILE MARKET REVENUE BY TYPE, 2014-2020 ($MILLION)
  • TABLE 11: WORLD HOME TEXTILE MARKET REVENUE BY GEOGRAPHY, 2014-2020 ($MILLION)
  • TABLE 12: WORLD RUG HOME TEXTILE MARKET REVENUE BY GEOGRAPHY, 2014-2020 ($MILLION)
  • TABLE 13: WORLD BATH HOME TEXTILE MARKET REVENUE BY GEOGRAPHY, 2014-2020 ($MILLION)
  • TABLE 14: WORLD BED HOME TEXTILE MARKET REVENUE BY GEOGRAPHY, 2014-2020 ($MILLION)
  • TABLE 15: WORLD KITCHEN & DINING HOME TEXTILE MARKET REVENUE BY GEOGRAPHY, 2014-2020 ($MILLION)
  • TABLE 16: WORLD LIVING ROOM HOME TEXTILE MARKET REVENUE BY GEOGRAPHY, 2014-2020 ($MILLION)
  • TABLE 17: WORLD FLOOR COVERING MARKET REVENUE BY TYPE, 2014-2020 ($MILLION)
  • TABLE 18: WORLD FLOOR COVERING MARKET BY GEOGRAPHY, 2014-2020 ($MILLION)
  • TABLE 19: WORLD TILE FLOOR COVERING MARKET REVENUE BY GEOGRAPHY, 2014-2020 ($MILLION)
  • TABLE 20: WORLD WOOD & LAMINATE FLOOR COVERING MARKET REVENUE BY GEOGRAPHY, 2014-2020 ($MILLION)
  • TABLE 21: WORLD VINYL & RUBBER FLOOR COVERING MARKET REVENUE BY GEOGRAPHY, 2014-2020 ($MILLION)
  • TABLE 22: WORLD CARPET & RUGS FLOOR COVERING MARKET REVENUE BY GEOGRAPHY, 2014-2020 ($MILLION)
  • TABLE 23: WORLD OTHER FLOOR COVERING MARKET REVENUE BY GEOGRAPHY, 2014-2020 ($MILLION)
  • TABLE 24: NORTH AMERICA HOME DECOR MARKET REVENUE BY PRODUCT, 2014-2020 ($MILLION)
  • TABLE 25: EUROPE HOME DECOR MARKET REVENUE BY PRODUCT, 2014-2020 ($MILLION)
  • TABLE 26: ASIA-PACIFIC HOME DECOR MARKET REVENUE BY PRODUCT, 2014-2020 ($MILLION)
  • TABLE 27: LAMEA HOME DECOR MARKET REVENUE BY PRODUCT, 2014-2020 ($MILLION)
  • TABLE 28: SNAPSHOT OF INTER IKEA GROUP
  • TABLE 29: SNAPSHOT OF FORBO INTERNATIONAL SA
  • TABLE 30: SNAPSHOT OF ARMSTRONG WORLD INDUSTRIES, INC.
  • TABLE 31: SNAPSHOT OF MANNINGTON MILLS INC.
  • TABLE 32: SNAPSHOT OF MOHAWK INDUSTRIES INC.
  • TABLE 33: SNAPSHOT OF SHAW INDUSTRIES
  • TABLE 34: SNAPSHOT OF HERMAN MILLER INC.
  • TABLE 35: SNAPSHOT OF ASHLEY FURNITURE INDUSTRIES, INC.
  • TABLE 36: SNAPSHOT OF KIMBALL INTERNATIONAL
  • TABLE 37: SNAPSHOT OF DURESTA UPHOLSTERY LTD.

List of Figures

  • FIG. 1: IVF DEVICES AND CONSUMABLES MARKET DEFINITION
  • FIG. 2: ASIA-PACIFIC ADOPTION RATE BY TYPE OF SURROGACY
  • FIG. 3: TOP IMPACTING FACTORS (2014-2020)
  • FIG. 4: TOP INVESTMENT POCKETS OF GLOBAL IVF DEVICES AND CONSUMABLES MARKET (2014-2020)
  • FIG. 5: TOP WINNING STRATEGIES IN GLOBAL IVF DEVICES AND CONSUMABLES MARKET 20122015
  • FIG. 6: TOP WINNING STRATEGIES IN GLOBAL IVF DEVICES AND CONSUMABLES MARKET, 2012-2015
  • FIG. 7: PORTERS FIVE FORCES ANALYSIS
  • FIG. 8: VALUE CHAIN ANALYSIS OF GLOBAL IVF MARKET
  • FIG. 9: PATENT ANALYSIS BY TYPE OF PATENTS (2011-2015)
  • FIG. 10: PATENT ANALYSIS BY GEOGRAPHY (2011-2015)
  • FIG. 11: EFFECT OF AGE ON FERTILITY
  • FIG. 12: COMPARISON OF THE MEDIA USED IN EMBRYO CULTURE
  • FIG. 13: SUCCESS RATE OF IVF TECHNIQUES PERFORMED BY AGE, 2013, U.S.
  • FIG. 14: PREGNANCY RATE, PER FROZEN EMBRYO TRANSFER, 2013 (U.S.)
  • FIG. 15: VITROLIFE AB, SALES PER REGION, 2014
  • FIG. 16: VITROLIFE AB, REVENUES ($MILLION), 2012-2014
  • FIG. 17: SWOT ANALYSIS OF VITROLIFE AB
  • FIG. 18: EMD SERONO SALES BY REGION, 2012
  • FIG. 19: SWOT ANALYSIS OF EMD SERONO, INC.
  • FIG. 20: SWOT ANALYSIS OF IRVINE SCIENTIFIC
  • FIG. 21: SWOT ANALYSIS OF COOPER SURGICAL, INC.
  • FIG. 22: SWOT ANALYSIS OF COOK MEDICAL, INC.
  • FIG. 23: THERMO FISHER SCIENTIFIC, INC. FINANCIAL REVENUES BY BUSINESS UNITS (2013)
  • FIG. 24: FINANCIAL REVENUES BY GEOGRAPHIC AREAS (2013)
  • FIG. 25: SWOT ANALYSIS OF THERMO FISHER SCIENTIFIC, INC.
  • FIG. 26: SWOT ANALYSIS OF GENEA BIOMEDX
  • FIG. 27: SWOT ANALYSIS OF AUXOGYN, INC.
  • FIG. 28: SWOT ANALYSIS OF OXFORD GENE TECHNOLOGY
  • FIG. 29: SWOT ANALYSIS OF OVASCIENCE, INC.
Back to Top